4.8 Article

Serine racemase binds to PICK1: potential relevance to schizophrenia

Journal

MOLECULAR PSYCHIATRY
Volume 11, Issue 2, Pages 150-157

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.mp.4001776

Keywords

schizophrenia; PICK1; serine racemase; D-serine; yeast two-hybrid; case-control study

Funding

  1. NIDA NIH HHS [DA00074] Funding Source: Medline
  2. NIMH NIH HHS [MH-18501, MH-069853] Funding Source: Medline
  3. NINDS NIH HHS [R01 NS036715, NS036715] Funding Source: Medline

Ask authors/readers for more resources

Accumulating evidence from both genetic and clinico-pharmacological studies suggests that D-serine, an endogenous coagonist to the NMDA subtype glutamate receptor, may be implicated in schizophrenia (SZ). Although an association of genes for D-serine degradation, such as D-amino acid oxidase and G72, has been reported, a role for D-serine in SZ has been unclear. In this study, we identify and characterize protein interacting with C-kinase (PICK1) as a protein interactor of the D-serine synthesizing enzyme, serine racemase (SR). The binding of endogenous PICK1 and SR requires the PDZ domain of PICK1. The gene coding for PICK1 is located at chromosome 22q13, a region frequently linked to SZ. In a case-control association study using well-characterized Japanese subjects, we observe an association of the PICK1 gene with SZ, which is more prominent in disorganized SZ. Our findings implicating PICK1 as a susceptibility gene for SZ are consistent with a role for D-serine in the disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available